AMGN
Amgen Inc. (AMGN)
Last Price$318.9(2.6%)
Market Cap$173.1B
LTM Return on Invested Capital (ROIC)
11.9%
5Y avg
15.3%
Drug Manufacturers - General industry median
14.7%
Stock quality & Intrinsic value
6/10
0.4% undervalued

Amgen Inc. Return on Invested Capital (ROIC)

Annual
Quarterly
LTM
Industry median
Company stand-alone
AMGN
Healthcare
Crunching data... Almost there!
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Return on Invested Capital (ROIC)
13.7%
9.8%
13.1%
17.3%
20.8%
21.1%
16.3%
19.3%
17.5%
15.3%
20.4%
23.6%
6.9%
27.8%
21.6%
11.1%
12.1%
10.2%
11.3%
11.2%
AMGN
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for AMGN and see if it's the right time to invest.
Dive in

Amgen Inc. (AMGN) Return on Invested Capital (ROIC) comparison analysis

AMGN key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
% growth
12,430.0
17.8%
14,268.0
14.8%
14,771.0
3.5%
15,003.0
1.6%
14,642.0
(2.4%)
15,053.0
2.8%
15,582.0
3.5%
17,265.0
10.8%
18,676.0
8.2%
20,063.0
7.4%
21,662.0
8.0%
22,991.0
6.1%
22,849.0
(0.6%)
23,747.0
3.9%
23,362.0
(1.6%)
25,424.0
8.8%
25,979.0
2.2%
26,323.0
1.3%
28,190.0
7.1%
33,424.0
18.6%
Cost of Goods Sold (COGS)2,082.02,095.02,548.02,296.02,091.02,220.02,427.02,918.03,346.04,422.04,227.04,162.04,069.04,101.04,356.06,159.06,454.06,406.08,415.012,858.0
% margin
10,348.0
83.3%
12,173.0
85.3%
12,223.0
82.7%
12,707.0
84.7%
12,551.0
85.7%
12,833.0
85.3%
13,155.0
84.4%
14,347.0
83.1%
15,330.0
82.1%
15,641.0
78.0%
17,435.0
80.5%
18,829.0
81.9%
18,780.0
82.2%
19,646.0
82.7%
19,006.0
81.4%
19,265.0
75.8%
19,525.0
75.2%
19,917.0
75.7%
19,775.0
70.1%
20,566.0
61.5%
Operating Expenses5,500.07,102.07,444.07,493.07,045.07,288.08,843.08,770.09,463.09,450.08,965.09,035.08,807.09,383.09,332.010,126.010,381.010,351.011,878.013,308.0
Research & Development Expenses (R&D)2,314.03,366.03,266.03,030.02,864.02,894.03,167.03,380.04,083.04,297.04,070.03,840.03,562.03,737.04,116.04,207.04,819.04,434.04,784.05,964.0
Selling, General & Administrative Expenses (SG&A)2,790.03,366.03,361.03,789.03,820.03,983.04,486.04,801.05,184.04,699.04,846.05,062.04,870.05,332.05,150.05,730.05,368.05,414.06,179.07,096.0
4,848.0
39.0%
3,840.0
26.9%
3,980.0
26.9%
5,214.0
34.8%
5,506.0
37.6%
5,545.0
36.8%
4,312.0
27.7%
5,577.0
32.3%
5,867.0
31.4%
6,191.0
30.9%
8,470.0
39.1%
9,794.0
42.6%
9,973.0
43.6%
10,263.0
43.2%
9,674.0
41.4%
5,794.0
22.8%
6,005.0
23.1%
5,335.0
20.3%
7,897.0
28.0%
7,258.0
21.7%
Interest Income0.00.00.0145.0276.0376.0448.0485.0420.0465.0603.0629.0928.0674.0753.0256.01,197.01,406.00.00.0
Interest Expense29.02,282.02,136.0344.0578.0604.0610.01,053.01,022.01,071.01,095.01,260.01,304.01,392.01,289.01,262.01,197.01,406.02,875.03,155.0
Pre-tax Income4,868.04,020.03,961.05,250.05,204.05,317.04,150.05,009.05,265.05,585.07,978.09,163.09,597.09,545.09,138.08,133.06,701.07,346.07,855.04,609.0
% effective tax rate
1,194.0
24.5%
1,070.0
26.6%
795.0
20.1%
1,054.0
20.1%
599.0
11.5%
690.0
13.0%
467.0
11.3%
664.0
13.3%
184.0
3.5%
427.0
7.6%
1,039.0
13.0%
1,441.0
15.7%
7,618.0
79.4%
1,151.0
12.1%
1,296.0
14.2%
869.0
10.7%
808.0
12.1%
794.0
10.8%
1,138.0
14.5%
519.0
11.3%
% margin
3,674.0
29.6%
2,950.0
20.7%
3,166.0
21.4%
4,196.0
28.0%
4,605.0
31.5%
4,627.0
30.7%
3,683.0
23.6%
4,345.0
25.2%
5,081.0
27.2%
5,158.0
25.7%
6,939.0
32.0%
7,722.0
33.6%
1,979.0
8.7%
8,394.0
35.3%
7,842.0
33.6%
7,264.0
28.6%
5,893.0
22.7%
6,552.0
24.9%
6,717.0
23.8%
4,090.0
12.2%
EPS2.972.512.833.794.534.824.075.616.756.809.1510.322.7112.7012.9612.4010.3412.1812.567.56
Diluted EPS2.932.482.823.774.514.794.045.526.646.709.0610.242.6912.6212.8812.3110.2812.1112.497.56
% margin
5,689.0
45.8%
7,265.0
50.9%
5,981.0
40.5%
6,639.0
44.3%
6,580.0
44.9%
6,671.0
44.3%
5,054.0
32.4%
6,356.0
36.8%
7,391.0
39.6%
8,747.0
43.6%
11,132.0
51.4%
11,937.0
51.9%
12,804.0
56.0%
12,883.0
54.3%
12,633.0
54.1%
12,929.0
50.9%
12,542.0
48.3%
12,093.0
45.9%
14,702.0
52.2%
13,356.0
40.0%

Discover more Stock Ideas

FAQ

1) What is Amgen Inc.'s Return on Invested Capital (ROIC)?

As of today, Microsoft Corp's last 12-month Return on Invested Capital (ROIC) is 11.9%, based on the financial report for Dec 31, 2024 (Q4’2024). The average annual Return on Invested Capital (ROIC) for Amgen Inc. have been 13.9% over the past three years, and 16.1% over the past five years.

2) Is Amgen Inc.'s Return on Invested Capital (ROIC) Good?

As of today, Amgen Inc.'s Return on Invested Capital (ROIC) is 11.9%, which is lower than industry median of 14.7%. It indicates that Amgen Inc.'s Return on Invested Capital (ROIC) is Bad.

3) How does Amgen Inc.'s Return on Invested Capital (ROIC) compare to its peers?

As of today, Amgen Inc.'s Return on Invested Capital (ROIC) is 11.9%, which is lower than peer median of 16.7%. The list of peers includes LLY, NVO, MRK, GILD, NVS, JNJ, AZN, PFE, ABBV, SNY.